Christopher Sells Named Vice President, Sales and Marketing
Erik Beuckelaers Named Vice President, Finance & HR
Dennis Moses Named Vice President, Engineering

Miami, FL, [December 19, 2018] — Neocis, Inc., the leader and innovator in dental implant surgery utilizing advanced robotics, announced today the addition of three experienced leaders in the medical device industry to the Company’s management team.

  • Christopher Sells has been named Vice President, Sales and Marketing. Sells most recently served as Vice President, New Business for Mazor Robotics where he was responsible for a number of key operational areas including new product launches and U.S. commercial optimization. He also served as Mazor’s Vice President of Sales as the company’s first U.S. employee. Previously, he held senior sales and operations roles with Hansen Medical, Intuitive Surgical, Neotonus, and Indigo Medical.
  • Erik Beuckelaers has been named Vice President, Finance & HR. He most recently served as Head of Finance, IT and Facilities at Verb Surgical, Inc., the surgical robotics and digital surgery joint venture between Johnson & Johnson and Google. Previously, Beuckelaers held numerousroles at Johnson & Johnson over nearly 10 years, including roles as Acclarent Head of Finance and Janssen R&D Manager Immunology Portfolio Strategy.
  • Dennis Moses has been named as Vice President, Engineering. Moses most recently served as Director of System Engineering for Verb Surgical, Inc. Prior, he served in numerous roles of increasing responsibility over nearly 15 years with Stryker Corporation. During his tenure, he participated in multiple major hardware and software releases and was successful in introducing and advancing a novel robotic solution for orthopedic surgery. Moses has led cross functional design and development efforts in various technologies and the medical device industry.

Mr. Sells, Mr. Beuckelaers, and Mr. Moses are part of the senior leadership team reporting directly to Alon Mozes, Chief Executive Officer.

“I am pleased to bring these strong executives to our senior management team during this pivotal stage in our company’s growth. Chris, Erik, and Dennis are all experienced industry leaders, each with a record of excellence and accomplishment in driving innovation, growth and operational improvements for a range of successful medical device and robotics companies. Following the addition of Dr. Fred Moll to the Neocis Board of Directors in July, we welcome the addition of these leaders who I am confident will add value as we change implant dentistry with the world’s first robot-assisted dental surgical system,” said Alon Mozes, Chief Executive Officer.

About Neocis, Inc.
Neocis® is a private company located in Miami, Florida that is transforming dental implant surgery with advanced robotics, with a vision of advancing healthcare through the latest technology. The company’s FDA cleared Neocis Guidance System, or Yomi®, is indicated for use to provide assistance in both the planning (pre-operative) and the surgical (intra-operative) phases of dental implantation surgery. The system provides software to preoperatively plan dental implantation procedures and provides navigational guidance of the surgical instruments. Yomi® provides surgical guidance through the use of haptic robotic technology, software, and multisensory feedback to help achieve the right position, angulation, and depth to place the implant exactly according to plan. Yomi® enables a minimally invasive flapless approach, which has been proven to lead to faster surgery, faster recovery, and less pain for the patient. Learn more at www.neocis.com

Contact
Leigh Salvo or Carrie Mendivil
(415) 937-5404
investors@neocis.com